Long-Term Outcomes Following Heart Team Revascularization Recommendations in Complex Coronary Artery Disease

Tiffany Patterson1, Hannah Z R McConkey1, Fiyyaz Ahmed-Jushuf2

  • 11 Division of Cardiovascular The Rayne Institute BHF Centre of Research Excellence King's College London St. Thomas' Hospital London United Kingdom.

Insights

The Heart Team (HT) approach for complex coronary artery disease (CAD) involves careful patient selection. This strategy leads to appropriate treatment decisions and good long-term survival outcomes for patients with complex CAD.

Area of Science:

  • Cardiology
  • Interventional Cardiology
  • Cardiac Surgery

Background:

  • Current guidelines recommend a Heart Team (HT) approach for complex coronary artery disease (CAD) with Class Ic evidence.
  • However, data on hard clinical endpoints for HT in complex CAD is limited.
  • This study investigates the characteristics and outcomes of patients with complex CAD managed by an HT.

Purpose of the Study:

  • To evaluate the characteristics of patients with complex coronary artery disease (CAD) discussed in Heart Team (HT) meetings.
  • To analyze the clinical outcomes and survival rates associated with different HT-guided treatment strategies.
  • To identify factors influencing the choice between optimal medical therapy (OMT) alone, OMT plus percutaneous coronary intervention (PCI), or OMT plus coronary artery bypass grafting (CABG).

Main Methods:

  • An observational study of 398 patients with complex CAD discussed in 51 Heart Team meetings.
  • Complex CAD included unprotected left main, 2-vessel (including proximal LAD), or 3-vessel disease, or cases with clinical/anatomical equipoise.
  • Treatment strategies were categorized as OMT alone, OMT + PCI, or OMT + CABG.

Main Results:

  • Patients had multivessel CAD (74.1%), high SYNTAX scores (median 30), and were a median age of 69 years.
  • Older patients with chronic kidney disease and peripheral vascular disease were less likely to receive PCI compared to OMT.
  • Coronary artery bypass grafting was less likely in patients with cardiogenic shock or left ventricular dysfunction, but more likely in younger patients with 3-vessel CAD.

Conclusions:

  • The Heart Team (HT) approach facilitates a careful selection process for complex coronary artery disease (CAD) patients.
  • This patient-specific decision-making process results in appropriate treatment strategies.
  • The HT approach is associated with good long-term survival outcomes in patients with complex CAD.

Related Concept Videos

Coronary Artery Disease I: Introduction01:30

Coronary Artery Disease I: Introduction

Coronary Artery Disease (CAD): An Overview with Scientific InsightsCoronary Artery Disease (CAD), often referred to as C-A-D, is a prevalent blood vessel disorder classified under the broader category of atherosclerosis. Atherosclerosis is a pathological process characterized by the hardening and narrowing of arteries due to the accumulation of atherosclerotic plaques. These plaques are composed of cholesterol, fatty substances, inflammatory cells, calcium, and fibrin, reducing blood flow to...
958
Coronary Artery Disease II: Pathophysiology01:26

Coronary Artery Disease II: Pathophysiology

Coronary Artery Disease (CAD) originates from a series of events that impair the function of coronary arteries, the blood vessels responsible for delivering oxygen-rich blood to the heart muscle. The pathophysiology of CAD is closely linked to atherosclerosis, a chronic inflammatory and lipid-driven condition affecting the vascular endothelium.1. Endothelial DamageThe process begins with damage to the vascular endothelium, which serves as a protective barrier between the blood and the vessel...
409
Coronary Artery Disease V: Interprofessional Care01:27

Coronary Artery Disease V: Interprofessional Care

Interprofessional care for coronary artery disease includes pharmacological therapy and revascularization procedures.Pharmacological therapy for Coronary Artery Disease (CAD) aims to manage symptoms, prevent complications, and improve patient outcomes through various classes of medications:Antiplatelet Agents:Aspirin and Clopidogrel: These medications inhibit platelet aggregation, preventing blood clots, which is crucial for avoiding heart attacks and strokes. Doctors often prescribe these...
238
Coronary Artery Disease IV: Preventive Measures01:26

Coronary Artery Disease IV: Preventive Measures

Effective preventive measures for coronary artery disease (CAD) focus on controlling modifiable risk factors, including cholesterol abnormalities and lifestyle changes.Cholesterol ManagementFirst, the Mediterranean diet and the American Heart Association advocate for maintaining low-density lipoprotein (LDL) cholesterol levels below 100 mg/dL, with a more stringent recommendation of below 70 mg/dL for individuals at high risk. LDL cholesterol, often termed "bad cholesterol," can lead to the...
622
Coronary Artery Disease III: Clinical Manifestations01:30

Coronary Artery Disease III: Clinical Manifestations

Coronary Artery Disease (CAD) is a primary health risk worldwide, leading to significant morbidity and mortality. The condition arises from the buildup of atherosclerotic plaques within the coronary arteries, resulting in diminished blood supply to the heart muscle.The clinical manifestations of CAD vary widely, from asymptomatic stages to severe, life-threatening conditions. Understanding these manifestations is crucial for early diagnosis and effective management.Angina Pectoris: The Warning...
358
Anatomy of the Heart01:27

Anatomy of the Heart

The human heart is made up of three layers of tissue that are surrounded by the pericardium, a membrane that protects and confines the heart. The outermost layer, closest to the pericardium, is the epicardium. The pericardial cavity separates the pericardium from the epicardium. Beneath the epicardium is the myocardium, the middle layer, and the endocardium, the innermost layer. There are four chambers of the heart: the right atrium, the right ventricle, the left atrium, and the left ventricle.
119.6K